Diosmin in combination with naringenin enhances apoptosis in colon cancer cells

Zeya,Bushra; Nafees,Sana; Imtiyaz,Khalid; Uroog,Laraib; Fakhri,Khalid Umar; Rizvi,M. Moshahid A.

doi:10.3892/or.2021.8215

Diosmin in combination with naringenin enhances apoptosis in colon cancer cells

Authors:
- Bushra Zeya
- Sana Nafees
- Khalid Imtiyaz
- Laraib Uroog
- Khalid Umar Fakhri
- M. Moshahid A. Rizvi
View Affiliations

Affiliations: The Genome Biology Laboratory, Department of Biosciences, Ramanujan Block, Jamia Millia Islamia, Jamia Nagar, New Delhi, Delhi 110025, India
Published online on: November 2, 2021 https://doi.org/10.3892/or.2021.8215
Article Number: 4

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colon cancer is one of the most commonly diagnosed malignancies, which begins as a polyp and grows to become cancer. Diosmin (DS) and naringenin (NR) are naturally occurring flavonoids that exhibit various pharmacological activities. Although several studies have illustrated the effectiveness of these flavonoids as anti‑cancerous agents individually, the combinatorial impact of these compounds has not been explored. In the present study, the combined effect of DS and NR (DiNar) in colon cancer cell lines HCT116 and SW480 were assessed by targeting apoptosis and inflammatory pathways. The MTT assay was used to evaluate the effect of DiNar on cell proliferation, while Chou‑Talalay analysis was employed to determine the combination index of DS and NR. Moreover, flow cytometry was used to monitor cell cycle arrest and population study. The onset of apoptosis was assessed by DAPI staining, DNA fragmentation, and Annexin V‑fluorescein isothiocyanate/propidium iodide (Annexin V‑FITC/PI). The expression levels of apoptotic pathway markers, Bcl‑2, Bax, caspase3, caspase8, caspase9 and p53, and inflammatory markers, NF‑κβ, IKK‑α and IKK‑β, were assessed using western blotting and reverse transcription‑quantitative PCR. These results suggested that DiNar treatment acts synergistically and induces cytotoxicity with a concomitant increase in chromatin condensation, DNA fragmentation and cell cycle arrest in the G0/G1 phase. Annexin V‑FITC/PI apoptosis assay also showed increased number of cells undergoing apoptosis in the DiNar treatment group. Furthermore, the expression of apoptosis and inflammatory markers was also more effectively regulated under the DiNar treatment. Thereby, these findings demonstrated that DiNar treatment could be a potential novel chemotherapeutic alternative in colon cancer.

View Figures

View References

1	Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI
2	American Cancer Society, . Colorectal Cancer: Facts and Figures 2021. American Cancer Society; 2021
3	Lee H, Choi DW, Cho YB, Yun SH, Kim HC, Lee WY, Heo JS, Choi SH, Jung KU and Chun HK: Recurrence pattern depends on the location of colon cancer in the patients with synchronous colorectal liver metastasis. Ann Surg Oncol. 21:1641–1646. 2014. View Article : Google Scholar : PubMed/NCBI
4	Longley DB, Harkin DP and Johnston PG: 5-fluorouracil: Mechanisms of action and clinical strategies. Nat Rev Cancer. 3:330–338. 2003. View Article : Google Scholar : PubMed/NCBI
5	Bleiberg H, Vandebroek A, Deleu I, Vergauwe P, Kalantari HR, Haens GD, Paesmans M, Peeters M, Efira A and Humblet Y: A phase II randomized study of combined infusion al leucovorin sodium and 5-FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatinin patients with metastatic colorectal cancer. Acta Gastroenterol Belg. 75:14–21. 2012.PubMed/NCBI
6	Verhoeyen ME, Bovy A, Collins G, Muir S, Robinson S, de Vos CH and Colliver S: Increasing antioxidant levels in tomatoes through modification of the flavonoids biosynthetic pathway. J Exp Bot. 53:2099–2106. 2002. View Article : Google Scholar : PubMed/NCBI
7	Mir IA and Tiku AB: Chemopreventive and therapeutic potential of ‘naringenin’, a flavanone present in citrus fruits. Nutr Cancer. 67:27–42. 2015. View Article : Google Scholar : PubMed/NCBI
8	Patel K, Singh GK and Patel DK: A review on pharmacological and analytical aspects of naringenin. Chin J Integr Med. 24:551–560. 2018. View Article : Google Scholar : PubMed/NCBI
9	Bodduluru LN, Kasala ER, Madhana RM, Barua CC, Hussain MI, Haloi P and Borah P: Naringenin ameliorates inflammation and cell proliferation in benzo(a)pyrene induced pulmonary carcinogenesis by modulating CYP1A1, NFκB and PCNA expression. Int Immunopharmacol. 30:102–110. 2016. View Article : Google Scholar : PubMed/NCBI
10	Park HJ, Choi YJ, Lee JH and Nam HJ: Naringenin causes ASK1-induced apoptosis via reactive oxygen species in human pancreatic cancer cells. Food Chem Toxicol. 99:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
11	Silambarasan T and Raja B: Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats. Eur J Pharmacol. 679:81–89. 2012. View Article : Google Scholar : PubMed/NCBI
12	Terao J, Piskula M and Yao Q: Protective effect of epicatechin gallate, and guercetin on lipid peroxidation in phospholipid bilayers. Arch Biochem Biophys. 308:278–284. 1994. View Article : Google Scholar : PubMed/NCBI
13	Naso L, Martínez VR, Lezama L, Salado C, Valcarcel M, Ferrer EG and Williams PAM: Antioxidant, anticancer activities and mechanistic studies of the flavone glycoside diosmin and its oxidovanadium(IV) complex. Interactions with bovine serum albumin. Bioorg Med Chem. 24:4108–4119. 2016. View Article : Google Scholar : PubMed/NCBI
14	Dung TD, Lin CH, Binh TV, Hsu HH, Su CC, Lin YM, Tsai CH, Tsai FJ, Kuo WW, Chen LM and Huang CY: Diosmin induces cell apoptosis through protein phosphatase 2A activation in HA22T human hepatocellular carcinoma cells and blocks tumour growth in xenografted nude mice. Food Chem. 132:2065–2073. 2012. View Article : Google Scholar
15	Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456–1462. 1995. View Article : Google Scholar : PubMed/NCBI
16	Attardi LD and Jacks T: The role of p53 in tumor suppression: Lessons from mouse models. Cell Mol Life Sci. 55:48–63. 1999. View Article : Google Scholar : PubMed/NCBI
17	Lowe SW and Lin AW: Apoptosis in cancer. Carcinogenesis. 21:485–495. 2000. View Article : Google Scholar : PubMed/NCBI
18	Terzic J, Grivennikov S, Karin E and Karin M: Inflammation and colon cancer. Gastroenterology. 138:2101–2114. 2010. View Article : Google Scholar : PubMed/NCBI
19	Lakatos PL and Lakatos L: Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies. World J Gastroenterol. 14:3937–3947. 2008. View Article : Google Scholar : PubMed/NCBI
20	Atreya I, Atreya R and Neurath MF: NF-kappaB in inflammatory bowel disease. J Intern Med. 263:591–596. 2008. View Article : Google Scholar : PubMed/NCBI
21	Yu H, Pardoll D and Jove R: STATs in cancer inflammation and immunity: A leading role for STAT3. Nat Rev Cancer. 9:798–809. 2009. View Article : Google Scholar : PubMed/NCBI
22	Shi X, Luo X, Chen T, Guo W, Liang C, Tang S and Mo J: Naringenin inhibits migration, invasion, induces apoptosis in human lung cancer cells and arrests tumour progression in vitro. J Cell Mol Med. 25:2563–2571. 2021. View Article : Google Scholar : PubMed/NCBI
23	Dung TC, Lin CH, Binh TV, Hsu HH, Su CC, Lin YM, Tsai CH, Tsai FJ, Kuo WW, Chen LM and Huang CY: Diosmin induces cell apoptosis through protein phosphatase 2A activation in HA22T human hepatocellular carcinoma cells and blocks tumour growth in xenografted nude mice. Food Chemistry. 132:2065–2073. 2012. View Article : Google Scholar
24	Khan N, Jajeh F, Eberhard EL, Miller DD, Albrecht DM, Van Doorn R, Hruby MD, Maresh ME, Clipson L, Mukhtar H and Halberg RB: Fisetin and 5-fluorouracil: Effective combination for PIK3CA-mutant colorectal cancer. Int J Cancer. 145:3022–3032. 2019. View Article : Google Scholar : PubMed/NCBI
25	Xu Z, Huang B, Liu J, Wu X, Luo N, Wang X, Zheng X and Pan X: Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes. Toxicology. 410:231–246. 2018. View Article : Google Scholar : PubMed/NCBI
26	Huang Y, Yuan K, Tang M, Yue J, Bao L, Wu S, Zhang Y, Li Y, Wang Y, Ou X, et al: Melatonin inhibiting the survival of human gastric cancer cells under ER stress involving autophagy and Ras-Raf-MAPK signaling. J Cell Mol Med. 25:1480–1492. 2021. View Article : Google Scholar : PubMed/NCBI
27	Morgan DM: Tetrazolium (MTT) assay for cellular viability and activity. Methods Mol Biol. 79:179–183. 1998.PubMed/NCBI
28	Chou TC and Talalay P: Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 22:27–55. 1984. View Article : Google Scholar : PubMed/NCBI
29	Chou TC: Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 58:621–681. 2006. View Article : Google Scholar : PubMed/NCBI
30	Zhang N, Wu ZM, McGowan E, Shi J, Hong ZB, Ding CW, Xia P and Di W: Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: Therapeutic potential for ovarian cancer. Cancer Sci. 100:2459–2464. 2009. View Article : Google Scholar : PubMed/NCBI
31	Nafees S, Mehdi SH, Zafaryab M, Zeya B, Sarwar T and Rizvi MM: Synergistic interaction of Rutin and Silibilin on human colon cancer cell line. Arch Med Res. 49:226–234. 2018. View Article : Google Scholar : PubMed/NCBI
32	Irshad M, Mehdi SJ, Al-Fatlawi AA, Zafaryab M, Ali A and Ahmad I: Phytochemical Composition of Cassia fistula fruit extracts and its anticancer activity against human cancer cell lines. J Biol Act Prod Nat. 4:158–170. 2014.
33	Wu M, Lao Y, Xu N, Wang X, Tan H, Fu W, Lin Z and Xu H: Guttiferone K induces autophagy and sensitizes cancer cells to nutrient stress-induced cell death. Phytomedicine. 22:902–910. 2015. View Article : Google Scholar : PubMed/NCBI
34	Liu L, Fan J, Ai G, Liu J, Luo N, Li C and Cheng Z: Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells. Biol Res. 52:372019. View Article : Google Scholar : PubMed/NCBI
35	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
36	Saraste A and Pulkki K: Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 45:528–537. 2000. View Article : Google Scholar : PubMed/NCBI
37	Hollman PC and Katan MB: Dietary flavonoids: Intake, health effects and bioavailability. Food Chem Toxicol. 37:937–942. 1999. View Article : Google Scholar : PubMed/NCBI
38	Ren W, Qiao Z, Wang H, Zhu L and Zhang L: Flavonoids: Promising anticancer agents. Med Res Rev. 23:519–534. 2003. View Article : Google Scholar : PubMed/NCBI
39	Mishra J, Dromund J, Quazi SH, Karanki SS, Shaw JJ, Chen B and Kumar N: Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis. Crit Rev Oncol Hematol. 86:232–250. 2003. View Article : Google Scholar : PubMed/NCBI
40	Key TJ: Fruit and vegetables and cancer risk. Br J Cancer. 104:6–11. 2004. View Article : Google Scholar
41	Park JH, Jin CY, Lee BK, Kim GY, Choi YH and Jeong YK: Naringenin induces apoptosis through downregulation of Akt and caspase-3 activation in human leukemia THP-1 cells. Food Chem Toxicol. 46:3684–3690. 2008. View Article : Google Scholar : PubMed/NCBI
42	Totta P, Acconcia F, Leone S, Cardillo I and Marino M: Mechanisms of Naringenin-induced apoptotic cascade in cancer cells: Involvement of estrogen receptor ?? and ?? Signalling. IUBMB Life. 56:491–499. 2004. View Article : Google Scholar : PubMed/NCBI
43	Lewinska A, Grochala JA, Kwasniewicz E, Deregowska A and Wnuk M: Diosmin induced senescence, apoptosis and autophagy in breast cancer cells of different p53 status and ERK activity. Toxicol Lett. 265:117–130. 2017. View Article : Google Scholar : PubMed/NCBI
44	Lewinska A, Siwak J, Rzezutek I and Wnuk M: Diosmin induces genotoxicity and apoptosis in DU145 prostate cancer cell line. Toxicol In Vitro. 29:417–425. 2015. View Article : Google Scholar : PubMed/NCBI
45	Lewin B, Cassimeris L and Lingappa VR: Cell, Jones & Bartlett Publishers; 2015
46	Stewart ZA, Westfall MD and Pietenpol JA: Cell cycle dysregulation and anticancer therapy. Trends Pharmacol Sci. 24:139–145. 2003. View Article : Google Scholar : PubMed/NCBI
47	Mills CC, Kolb EA and Sampson VB: Development of chemotherapy with cell-cycle inhibitors for adult and pediatric cancer therapy. Cancer Res. 78:320–325. 2018. View Article : Google Scholar : PubMed/NCBI
48	Arul D and Subramanian P: Naringenin (Citrus Flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Pathol Oncol Res. 19:763–770. 2013. View Article : Google Scholar : PubMed/NCBI
49	Khan KH, Codesido MB and Molife LR: Cancer therapeutics: Targeting the apoptotic pathway. Crit Rev Oncol Hematol. 90:200–219. 2014. View Article : Google Scholar : PubMed/NCBI
50	Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
51	Kerr JF, Wyllie AH and Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:239–257. 1972. View Article : Google Scholar : PubMed/NCBI
52	Jurisicova A, Varmuza S and Casper RF: Programmed cell death and human embryo fragmentation. Mol Hum Reprod. 2:93–98. 1996. View Article : Google Scholar : PubMed/NCBI
53	Ahamad MS, Siddiqui S, Jafri A, Ahmad S and Afzal M: Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest. PLoS One. 9:e1100032014. View Article : Google Scholar : PubMed/NCBI
54	Kagan VE, Fabisiak JP, Shvedova AA, Tyurina YY, Tyurin VA, Schor NF and Kawai K: Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis. FEBS Lett. 477:1–7. 2000. View Article : Google Scholar : PubMed/NCBI
55	Kojima M, Morisaki T, Sasaki N, Nakano K, Mibu R, Tanaka M and Katano M: Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression. Anticancer Res. 24:675–681. 2004.PubMed/NCBI
56	Naugler WE and Karin M: NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev. 18:19–26. 2008. View Article : Google Scholar : PubMed/NCBI